DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/03/3108-1016-1026$20.00
DMD 31:1016-1026, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nunoya, K.
Right arrow Articles by Deeley, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nunoya, K.
Right arrow Articles by Deeley, R. G.

MOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)

Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole1, and Roger G. Deeley2

Department of Xenobiotic Metabolism and Disposition, Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan (K.N.); and Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (C.E.G., D.Z., S.P.C.C., R.G.D.)

Multidrug resistance protein 1 (MRP1) transports a wide range of structurally diverse conjugated and nonconjugated organic anions and some peptides, including oxidized and reduced glutathione (GSH). The protein confers resistance to certain heavy metal oxyanions and a variety of natural product-type chemotherapeutic agents. Elevated levels of MRP1 have been detected in many human tumors, and the protein is a candidate therapeutic target for drug resistance reversing agents. Previously, we have shown that human MRP1 (hMRP1) and murine MRP1 (mMRP1) differ in their substrate specificity despite a high degree of structural conservation. Since rat models are widely used in the drug discovery and development stage, we have cloned and functionally characterized rat MRP1 (rMRP1). Like mMRP1 and in contrast to hMRP1, rMRP1 confers no, or very low, resistance to anthracyclines and transports the two estrogen conjugates, 17ß-estradiol-17-(ß-D-glucuronide) (E217ßG) and estrone 3-sulfate, relatively poorly. Mutational studies combined with vesicle transport assays identified several amino acids conserved between rat and mouse, but not hMRP1, that make major contributions to these differences in substrate specificity. Despite the fact that the rodent proteins transport E217ßG poorly and the GSH-stimulated transport of estrone 3-sulfate is low compared with hMRP1, site-directed mutagenesis studies indicate that different nonconserved amino acids are involved in the low efficiency with which each of the two estrogen conjugates is transported. Our studies also suggest that although rMRP1 and mMRP1 are 95% identical in primary structure, their substrate specificities may be influenced by amino acids that are not conserved between the two rodent proteins.


Address correspondence to: Dr. Roger G. Deeley, Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Botterell Hall, Queen's University, Kingston, Ontario K7L 3N6, Canada. E-mail: deeleyr{at}post.queensu.ca




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Sun, L. Liu, and K. S. Pang
Increased Estrogen Sulfation of Estradiol 17beta-D-Glucuronide in Metastatic Tumor Rat Livers
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 818 - 831.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Hanggi, A. F. Grundschober, S. Leuthold, P. J. Meier, and M. V. St-Pierre
Functional Analysis of the Extracellular Cysteine Residues in the Human Organic Anion Transporting Polypeptide, OATP2B1
Mol. Pharmacol., September 1, 2006; 70(3): 806 - 817.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev, July 1, 2006; 86(3): 849 - 899.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Dallas, D. S. Miller, and R. Bendayan
Multidrug resistance-associated proteins: expression and function in the central nervous system.
Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Tochigi, N. Yamashiki, S. Ohgiya, S. Ganaha, and H. Yokota
ISOFORM-SPECIFIC EXPRESSION AND INDUCTION OF UDP-GLUCURONOSYLTRANSFERASE IN IMMUNOACTIVATED PERITONEAL MACROPHAGES OF THE RAT
Drug Metab. Dispos., September 1, 2005; 33(9): 1391 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Yu, K. von Bergmann, D. Lutjohann, H. H. Hobbs, and J. C. Cohen
Selective sterol accumulation in ABCG5/ABCG8-deficient mice
J. Lipid Res., February 1, 2004; 45(2): 301 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-W. Zhang, H.-M. Gu, D. Situ, A. Haimeur, S. P. C. Cole, and R. G. Deeley
Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1): IDENTIFICATION OF AN ASPARTATE RESIDUE CRITICAL FOR CONVERSION FROM A HIGH TO LOW AFFINITY SUBSTRATE BINDING STATE
J. Biol. Chem., November 14, 2003; 278(46): 46052 - 46063.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.